Results 131 to 140 of about 51,875 (217)

Physiologically Based Pharmacokinetic Model of Brigatinib in Healthy Volunteers and Patients With Cancer. [PDF]

CPT Pharmacometrics Syst Pharmacol
Xu Y, Hu X, Zhao P, Wang L, Ruan Z, Jiang B, Lou H.   +6 more
europepmc   +1 more source

Levofloxacin-Catalase-PLGA Nanoparticles Potentiate Sonodynamic Therapy to Alleviate BCG-Induced Tuberculous Granulomas via PI3K/Akt/VEGF Pathway Suppression in Rats. [PDF]

Int J Nanomedicine
Qiu Y, Qin L, Shen S, Zhang Y, Du Y, Li D.   +5 more
europepmc   +1 more source

Repeated voriconazole therapeutic drug monitoring in hospitalised patients: a real-world cohort study of out-of-range exposure and concentration response to dose adjustment. [PDF]

Front Pharmacol
He T, Liu Z, Liang L, Qiao W, Chen S, Liu J, Liu M, Li W.   +7 more
europepmc   +1 more source

Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV. [PDF]

Open Forum Infect Dis
Dyer E, Sunagawa SW, Regan N, Davis JM, Bares SH.   +4 more
europepmc   +1 more source

Management of Infective Endocarditis: A Scoping Review. [PDF]

J Brown Hosp Med
Bogni FM, Gillette JS, Selvaraj V, Finn A, Zainah H, Lonks JR, Dapaah-Afriyie K.   +6 more
europepmc   +1 more source

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series

Tacrolimus is a cornerstone immunosuppressant in transplantation medicine with a narrow therapeutic window. Drug-drug interactions with strong CYP3A4 and P-glycoprotein modulators, such as rifampin and azole antifungals, significantly alter tacrolimus ...
Apotheek Onderzoek, Schönwetter, Rob H J, Uijtendaal, Esther V, de Vries Schultink, Aurelia H M, Ruigrok, Dieuwertje, Houwen, Jeroen P A, Longziekten, Medische Staf Intensive Care, Peters, Bas J M, Sikma, Maaike A, Apotheek Klinische Farmacie   +10 more
core  

A Physiologically Based Pharmacokinetic Model to Predict Potential Drug-Drug Interactions of TPN171, a Novel Phosphodiesterase Type 5 Inhibitor. [PDF]

CPT Pharmacometrics Syst Pharmacol
Tian G, Chen T, Li L, Wang Z, Yang H, Juan J, Duan Y, Pei J, Jia J.   +8 more
europepmc   +1 more source

Rifampin [PDF]

, 2020
openaire   +1 more source

Suzetrigine Is Not Expected to Have Clinically Relevant DDIs with Apixaban and Rivaroxaban Based on PBPK Modeling. [PDF]

J Clin Pharmacol
Wang G, Lakota E, Feng B, Jiang L, Liang G, Hare B.   +5 more
europepmc   +1 more source